What other stocks do shareholders of ARYA Sciences Acquisition Corp III own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ARYA Sciences Acquisition Corp III investors own include Trevena (TRVN) , Advanced Micro Devices (AMD) , BioXcel Therapeutics (BTAI) , ChromaDex (CDXC) , Chimerix (CMRX) , CTI BioPharma (CTIC) , DRDGOLD (DRD) and

When did ARYA Sciences Acquisition Corp III IPO?

ARYA Sciences Acquisition Corp III (ARYA) raised $125 million in an initial public offering on Friday, August 7th 2020. The company issued 12,500,000 shares at a price of $10.00 per share. Jefferies and Goldman Sachs acted as the underwriters for the IPO.

NASDAQ:ARYA

ARYA Sciences Acquisition Corp III (ARYA) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free ARYA Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $10.77
▼
$11.25
50-Day Range: $9.91
▼
$11.16
52-Week Range: $9.82
▼
$25.89

Volume: 366,228 shs
Average Volume: 320,123 shs
Market Capitalization: $186.48 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get ARYA Sciences Acquisition Corp III alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About ARYA Sciences Acquisition Corp III

ARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

Ad Crypto 101 Media

SHOCKING Crypto Leak…

Claim your free seat by clicking here now.

ARYA Stock News Headlines

March 16, 2024 | msn.com

Arya Resources Ltd. (RBZ) Drills 3.5 Kilogram per Tonne (Kg. /t) Copper, 6.1 Kg. /t Nickel, and 0.247 Kg. /t Cobalt Over 36.5 Meters

February 10, 2024 | msn.com

ARYA Sciences Acquisition IV Announces New Financial Obligation

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

February 10, 2024 | markets.businessinsider.com

ARYA Sciences Secures Convertible Sponsor Loan

February 3, 2024 | msn.com

ARYA Sciences Acquisition IV Extends Business Combination Period

July 3, 2023 | finance.yahoo.com

ARYA Sciences Acquisition Corp V will redeem its Class A Ordinary Shares and will not consummate an initial business combination

July 3, 2023 | marketwatch.com

Arya Sciences Acquisition to Redeem Shares

September 12, 2022 | finance.yahoo.com

ATEX Mobilizes Drill Contractor for Phase III Program and Makes Third Option Payment on Valeriano

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

September 7, 2022 | apnews.com

ArisGlobal Accelerates Growth, Announces Executive Evolution

August 1, 2022 | seekingalpha.com

ON Semiconductor Corporation (ON) CEO Hassane El-Khoury on Q2 2022 Results - Earnings Call Transcript

June 8, 2022 | nz.finance.yahoo.com

Akili Announces Veteran Life Sciences Executive Matt Franklin in Newly Created Role of President and Chief Operating Officer

June 2, 2022 | msn.com

Arya.ag acquires autonomous AI agritech player Prakshep

February 24, 2022 | msn.com

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company

November 7, 2021 | thestreet.com

TradeStation Group Strikes SPAC Deal with Quantum FinTech (QFTA)

October 1, 2021 | law360.com

Don't Miss It: Latham, Cravath Guide Week's Hot Deals

August 24, 2021 | nasdaq.com

Jefferies Top Analysts Press the ‘Buy’ Button on These 3 Stocks

July 24, 2021 | thestreet.com

CCIV Adjourns Lucid Shareholder Meeting, Urges Retail Participation

See More Headlines

Receive ARYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARYA Sciences Acquisition Corp III and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: N/A
Industry: Holding & Other Investment Offices
Sub-Industry: N/A
Current Symbol: NASDAQ:ARYA
CUSIP: N/A
CIK: N/A
Web: www.perceptivelife.com
Phone: 212-284-2300
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.52
Quick Ratio: 0.52

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.30 per share
Price / Book: 37.20

Miscellaneous

Outstanding Shares: 16,710,000
Free Float: N/A
Market Cap: $186.48 million
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Adam Leo Stone (Age 42)
CEO & Director
Mr. Michael Seth Altman C.F.A. (Age 39)
CFA, CFO & Director
Mr. Konstantin Poukalov (Age 37)
Chief Bus. Officer

ARYA Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of ARYA Sciences Acquisition Corp III own?: Based on aggregate information from My MarketBeat watchlists, some companies that other ARYA Sciences Acquisition Corp III investors own include Trevena (TRVN), Advanced Micro Devices (AMD), BioXcel Therapeutics (BTAI), ChromaDex (CDXC), Chimerix (CMRX), CTI BioPharma (CTIC), DRDGOLD (DRD) and
When did ARYA Sciences Acquisition Corp III IPO?: ARYA Sciences Acquisition Corp III (ARYA) raised $125 million in an initial public offering on Friday, August 7th 2020. The company issued 12,500,000 shares at a price of $10.00 per share. Jefferies and Goldman Sachs acted as the underwriters for the IPO.

This page (NASDAQ:ARYA) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

ARYA Sciences Acquisition Corp III (ARYA) Stock Price, News & Analysis

About ARYA Sciences Acquisition Corp III

ARYA Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

ARYA Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info